ARTICLE | Company News
Viragen infectious diseases news
May 10, 1999 7:00 AM UTC
VRGN is changing its focus from process manufacturing to clinical development now that its preclinical work on Omniferon multitype natural interferon alpha to treat hepatitis C is complete. As a resul...